KENALOG Trademark

Trademark Overview

On Thursday, June 6, 2024, a trademark application was filed for KENALOG with the United States Patent and Trademark Office. The USPTO has given the KENALOG trademark a serial number of 98588654. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, April 1, 2025. This trademark is owned by Rising Pharma Holdings, Inc.. The KENALOG trademark is filed in the Pharmaceutical Products category with the following description:

Steroid preparations; corticosteroid preparations; glucocorticoid preparations

General Information

Serial Number98588654
Word MarkKENALOG
Filing DateThursday, June 6, 2024
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, April 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2025

Trademark Statements

Goods and ServicesSteroid preparations; corticosteroid preparations; glucocorticoid preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, April 1, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRising Pharma Holdings, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEast Brunswick, NJ 08816
Party NameRising Pharma Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEast Brunswick, NJ 08816

Trademark Events

Event DateEvent Description
Thursday, June 6, 2024NEW APPLICATION ENTERED
Tuesday, August 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 6, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, November 6, 2024NON-FINAL ACTION WRITTEN
Wednesday, November 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 6, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 28, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 5, 2024ASSIGNED TO EXAMINER
Tuesday, November 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 31, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 25, 2025PUBLISHED FOR OPPOSITION
Friday, January 31, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 31, 2025ASSIGNED TO LIE
Sunday, February 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, March 13, 2025EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, March 31, 2025TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, April 1, 2025ABANDONMENT - AFTER PUBLICATION
Tuesday, April 1, 2025ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION

Related Keywords

kenalog preparations glucocorticoid corticosteroid steroid